BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $228,000 | -13.6% | 2,670 | -13.7% | 0.05% | -16.4% |
| Q1 2021 | $264,000 | +10.9% | 3,095 | 0.0% | 0.06% | +1.9% |
| Q4 2020 | $238,000 | -4.8% | 3,095 | 0.0% | 0.05% | -11.5% |
| Q3 2020 | $250,000 | -6.0% | 3,095 | 0.0% | 0.06% | -23.8% |
| Q2 2020 | $266,000 | +2.7% | 3,095 | -3.1% | 0.08% | -11.1% |
| Q1 2020 | $259,000 | -3.0% | 3,195 | 0.0% | 0.09% | +26.8% |
| Q4 2019 | $267,000 | -1.5% | 3,195 | +3.2% | 0.07% | -7.8% |
| Q3 2019 | $271,000 | +11.5% | 3,095 | +4.2% | 0.08% | +10.0% |
| Q2 2019 | $243,000 | +0.8% | 2,970 | 0.0% | 0.07% | 0.0% |
| Q1 2019 | $241,000 | -7.3% | 2,970 | -20.2% | 0.07% | -31.4% |
| Q2 2015 | $260,000 | +2.0% | 3,722 | 0.0% | 0.10% | +2.0% |
| Q1 2015 | $255,000 | -6.6% | 3,722 | 0.0% | 0.10% | -7.4% |
| Q4 2014 | $273,000 | -3.9% | 3,722 | -5.8% | 0.11% | -6.9% |
| Q3 2014 | $284,000 | -0.7% | 3,952 | 0.0% | 0.12% | +3.6% |
| Q2 2014 | $286,000 | -43.3% | 3,952 | -42.3% | 0.11% | -43.7% |
| Q1 2014 | $504,000 | -10.8% | 6,847 | -15.7% | 0.20% | -16.7% |
| Q4 2013 | $565,000 | +6.8% | 8,127 | +0.9% | 0.24% | -1.2% |
| Q3 2013 | $529,000 | +74.0% | 8,052 | +83.8% | 0.24% | +65.8% |
| Q2 2013 | $304,000 | -4.4% | 4,382 | 0.0% | 0.15% | +0.7% |
| Q1 2013 | $318,000 | +8.9% | 4,382 | 0.0% | 0.14% | -1.4% |
| Q4 2012 | $292,000 | +10.6% | 4,382 | 0.0% | 0.15% | +20.5% |
| Q3 2012 | $264,000 | -14.0% | 4,382 | -24.2% | 0.12% | -14.7% |
| Q2 2012 | $307,000 | -11.3% | 5,782 | 0.0% | 0.14% | -9.5% |
| Q1 2012 | $346,000 | – | 5,782 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |